Sunday, 12 March 2017

Week 83 Review

A week of ups and downs, but fortunately more ups than downs, with the combined portfolios gaining £553 and reducing the paper loss to £212, with the overall portfolio sale value going above £60,000 for the first time - Woohoo!!

Last week's Share of the Week is this week's biggest loser, with JLP:Jubilee Platinum dropping 22% and even worse, my SIPP holding dropped 77% as a result of me topping up prior to the price falling further. I can't understand why it fell so far given the relentless news. If news of maiden platinum production at Hernic comes out next week then the gains should be put back straight away.

OPTI:Optibiotix is getting really exciting now, with the announcement of a deal with Sacco giving the share price an 11% boost, but with the big seller still selling, it's not likely to break free just yet.

TND:Tandem Group should have done enough to earn Share of the Week with a climb of 13% after great results. No sign of the re-rate this deserves but there is a lot more hope.

Unfortunately Share of the Week is awarded to BLUR:Blur Group which rose 28% after announcement of another contract. Maybe they won't go bust after all!

Here's the combined ISA and share accounts



Weekly Change
Portfolio cost£42,680.95
+£0
Portfolio sell value (bid price - commission)£40,048.00(-6.2%)+£990.13
Potential profits£3,200.23
-£73.99
Yr 2 Dividends£357.10
0
Yr 2 Profit from sales£3,409.68
0
Yr 2 Average monthly cash profit£522.87
-£17.43
Yr 2 Avg annual % of current portfolio cost14.7%
Total Dividends£1,025.03
0
Total Profit from sales£7,249.94
0
Average monthly cash profit£427.51
-£5.21
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost12.0%

Big increase in value of £990 and practically all was reduction of losses, as the big drop in JLP:Jubilee Platinum meant potential profits went down overall. No sales or dividends.


What an absolutely fantastic sight!

The SIPP looks like this after week 67



Weekly Change
Portfolio cost£16,776.69
+£259.52
Portfolio sell value (bid price - commission)£19,329.57(+15.2%)-£464.50
Potential profits£3,085.25
-£715.48
Yr 2 Dividends£0
+£0
Yr 2 Profit from sales£842.07
+£266.22
Yr 2 Average monthly cash profit£146.99
+£43.77
Yr 2 Avg annual % of current portfolio cost10.5%
Total Dividends£413.19
+£0
Total Profit from sales£3,191.93
+£266.22
Average monthly cash profit£228.08
+£14.03
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost16.3%

Portfolio cost is up after re-investing the profits from selling RED:RedT Energy and buying JLP:Jubilee Platinum, which promptly tanked and explains the £464 decline in portfolio value and £715 drop in potential profit. CAML:Central Asian Metals fell another 9% which was very costly. Big plus from the sale is that year 2 profits are above my 10% target, and overall monthly performance sneaked up another £14 and is now a really good 16.3%. With the paper profits at 15.2% the pension is very healthy despite this week's dip.


Worrying trend developing of cost increasing and value at best staying flat

The trading account looks like this after week 33



Weekly Change
Portfolio cost£986.03
+£0
Cash£75.59
+£0
Portfolio sell value (bid price - commission)£853.46(-13.4%)+£27.89
Potential profits£0
+£0
Dividends£0
0
Profit from sales£61.57
+£0
Average monthly cash profit£8.08
-£0.26
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost9.8%

A slight recovery in REDS:RedstoneConnect sees the portfolio value sneak up £27, but the boost to allow a sale is nowhere in sight.


Going in the right direction, but slowly.

This week has been a relentless stream of exciting news. I doubt next week can match it, but I'm hoping the share prices will start to reflect the true value of last week's news and break through the final £212 to take the portfolio into paper profit.

Tuesday, 7 March 2017

Aborted De-risk Manoeuvre

Over the weekend I looked through my portfolio to see if there was some more de-risking I could do, and further my plans to increase my overall holding in IQE:IQE to 10% of my portfolio.

I decided that the share to sacrifice would be RED:RedT Energy in my SIPP. This was up by 11% and I still have £1,000 worth in my ISA, which I think is the most I should be risking in this volatile share.

This morning the RED:RedT Energy share price went up by 9% so I was in like a shot and sold 12,923 for 10.57p after paying 8.37p, making £266.22 (23.8%) profit.

I was about to re-invest the proceeds in IQE:IQE when I paused. JLP:Jubilee Platinum had soared at the end of last week when the announcement was made that the Tjate mining licence had been approved. This is now my Star Share, but I noticed the price had dropped significantly today.

It appears there are warrants being sold off, and with news of maiden platinum production at Hernic almost certainly imminent, work about to start on a small platinum plant at ASA and rumours of another project in the pipeline, I couldn't help myself.

I bought another 22,525 at 5.955p costing £1,350.31 taking my total holding to 110,306. This is now 7% of my portfolio and I really believe it has the potential to be huge, with a multi-billion dollar asset at Tjate and imminent low-cost platinum production. The biggest risk to potential wealth is that a takeover bid comes in while the market cap is still only £58.6m.

Despite the drop in share price this week, JLP:Jubileee Platinum is still my Star Share by £600 with potential profit of £1,840. The nearest rival is CAML:Central Asia Metals at £1,257 despite a recent dip, and not far behind is IQE:IQE on £1,208.

OPTI:Optibiotix is still Nemesis Share, losing £1,005.  KIBO:Kibo Mining isn't far behind losing £991, and AFG:Aquatic Food is losing £972. Rather amazing really, as I thought Nemesis Share would be AFPO:African Potash by now, as it's down 101% and would cost me £6.38 if I were to sell it, losing £714. They've just paid their director's salaries in shares the cash is so tight. Normally I'd be encouraged by that, but it smacks of desperation.

It's been a very eventful day even without my sale and purchase. BLUR:Blur Group announced a new contract and the price finished the day up by 118%. At one point during the day it was up over 200% so someone made a lot of money. Despite this, my holding is still 60% down and I doubt will be in profit for a long, long time if ever.

There were three other double-digit risers today, with RED:RedT Energy climbing 11% and prompting me to sell half my holding. If I'd waited a few more hours I would have got 2% more than I got and paid 3% less for JLP:Jubileee Platinum - never mind...

RED:RedstoneConnect was up 10% after announcing a swing into profit, which is great news for my trading account where they are only down by £51 so a small increase will see me start thinking about how much short term profit to take.

My most sleepy share TND:Tandem Group climbed a whopping 24% after announcing a very positive trading statement. These are still 40% down and losing £435 but there's a glimmer of hope I'll be able to get rid of them soon, as with a P/E ratio of only 6 and increasing profits, they could be on for a major re-rate.

Great news that both AMYT:Amryt Pharma and OPTI:Optibiotix have recovered a little, off-setting the effect of the (temporary) drop in JLP:Jubilee Platinum so I'm only down by £162 on last week despite banking a load of profit.

Tomorrow LOOK:Lookers release their results and based on previous trading statements I expect them to be good. That share has been really irritating as it's been 30% down ever since Brexit and has a puny P/E ratio of just 10. The market for second hand cars is strong, and they have made some great acquisitions lately, but I have £2,000 tied up in them and am losing £607. They are in my standard share account so I would love to be able to sell them for a small profit and transfer the funds to my ISA in April to add some more IQE:IQE, but I may be too late if the price of IQE keeps going up at this rate.

I have a feeling that if a number of things could all come together over the next few days, there's a real hope the combined portfolio could finally get into profit. Every time it looks imminent something horrible scuppers it, but this week I may just hold my breath...

Friday, 3 March 2017

Week 82 Review

I'm starting to really dislike Fridays. The number of times Thursday has ended great and I've been all set for a bumper weekly update, and Friday comes along and buggers it all up. Yesterday I was within £70 of breaking even on the combined portfolios, and now I'm £766 in the red thanks to OPTI:Optibiotix losing all this week's gains and KIBO:Kibo Mining dropping back below 5p after getting above it in mid-week. I shouldn't be too grumpy, as this position is still £1,485 better than it was last week, so it has been a stunning week despite Friday.

Worst loser this week was TLOU:Tlou Energy dropping 14% so I'm really happy I sold nearly half my holding last week. SLP:Sylvania Platinum suffered from profit taking and dropped 11%, and rather surprisingly given the price of copper, CAML:Central Asia Metals dropped 10% very quietly over the week which is hundreds of pounds gone off my paper profits.

There were good news stories though, with IQE:IQE climbing 10%, but the biggest good news story was JLP:Jubilee Platinum which climbed a staggering 54% and is not only Share of the Week, but has booted CAML:Central Asia Metals off the Star Share position with a stunning £2,686.85 potential profit.

The share and ISA portfolios look like this



Weekly Change
Portfolio cost£42,680.95
+£0
Portfolio sell value (bid price - commission)£39,057.87(-8.5%)+£1,184.57
Potential profits£3,274.22
+£1,134.75
Yr 2 Dividends£357.10
0
Yr 2 Profit from sales£3,409.68
0
Yr 2 Average monthly cash profit£540.30
-£19.19
Yr 2 Avg annual % of current portfolio cost15.2%
Total Dividends£1,025.03
0
Total Profit from sales£7,249.94
0
Average monthly cash profit£432.72
-£5.54
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost12.2%

Big boost to profits from JLP:Jubilee Platinum. It single-handedly saved the portfolio this week as there wasn't much else to smile about. No dividends or sales so average performance drops off a tiny amount.


Go green line go!

The SIPP looks like this after week 66



Weekly Change
Portfolio cost£16,517.17
-£8.02
Portfolio sell value (bid price - commission)£19,534.55(+18.3%)+£299.11
Potential profits£3,800.73
+£307.60
Yr 2 Dividends£0
+£0
Yr 2 Profit from sales£575.85
0
Yr 2 Average monthly cash profit£103.22
-£6.02
Yr 2 Avg annual % of current portfolio cost7.5%
Total Dividends£413.19
+£0
Total Profit from sales£2,925.71
+£0
Average monthly cash profit£214.05
-£3.75
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost15.6%

Not sure what happened with the portfolio cost - I suspect a typo last week as there's nothing to account for the vanishing £8.02. Most of the increase in profit was thanks to JLP:Jubilee Platinum, with a contribution from IQE:IQE which has moved from loss to £89 profit this week.


Green line establishing its upward trend once more.

The trading account looks like this after week 32



Weekly Change
Portfolio cost£986.03
+£0
Cash£75.59
+£0
Portfolio sell value (bid price - commission)£825.57(-16.3%)+£10.21
Potential profits£0
+£0
Dividends£0
0
Profit from sales£61.57
+£0
Average monthly cash profit£8.34
-£0.27
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost10.1%

KIBO:Kibo Mining snuck up a tiny bit but RED:RedstoneConnect dropped a teeny bit, so we're £10 better off.


Troubling. Hope I don't have to wait as long to sell these as I did the last time!

Interesting news from KIBO:Kibo Mining about the reverse takeover of OPRA:Opera Investments to set up the new company Katoro Mining. Kibo get 61m shares as part of the deal, which would be one share for every 6 of Kibo's. I'm hoping these shares will be destined for shareholders, as I would get 11,846 which at 6p a share would be worth £710.76. That would be nice!

Thursday, 2 March 2017

Jubilee Platinum Soars

At last! The mining licence was granted for Tjate and JLP:Jubilee Platinum has gone into orbit!

The share price was up 50% at one point, but settled to an increase of 36% on more than 100 million trades.

This propelled Jubilee straight into the position of Star Share, making potential profit of £2,555. The ISA holding is up by 63%, share account by 88% and SIPP by 103%,

This is on the day of the news - and before the news has broken on platinum production at Hernic

The 18 month wait and regular top-ups on dips have all paid off.

This is the first time one of my favourite shares has done something like this on news. It's brilliant - and I've loved reading all the comments on the Advfn bulletin board - lots of very happy holders.

The impact on the main portfolio has been staggering, with the combined value up by £2,181 this week. It's still at a paper loss, but just £70. I could be writing a very happy end of week review tomorrow, especially if momentum builds and Jubilee climbs some more, as 6.326p is still ridiculously cheap.

Booked a flight to Costa Rica today - and is cost less than half what Jubilee made me! Woohoo!!

There haven't been many days like this so I'm going to make the most of it. Time for the pub and a celebratory pint!

Friday, 24 February 2017

Week 81 Review - Lots of Sales

This week was a heady mix of sells and consolidation while all around me the portfolio tanked. It's going to be a complicated week to analyse, as I banked a lot of profit, so the paper loss widened dramatically. This in combination with nearly all the shares decreasing in value meant the portfolio ended up £1,743.99 worse off than last week at a paper loss of £2,260.05. Given I banked £994.98 profit, that means the portfolio declined by £749.01.

There was only one double-digit changer this week and it was a loss. SLP:Sylvania Platinum fell victim to profit taking and declined by 12%.

I'll cover the sales and purchases in the accounts for each portfolio.

The combined ISA and share account portfolio looks like this



Weekly Change
Portfolio cost£42,680.95
+£562.86
Portfolio sell value (bid price - commission)£37,873.30(-11.3%)-£1,128.93
Potential profits£2,139.47
-£506.80
Yr 2 Dividends£357.10
0
Yr 2 Profit from sales£3,409.68
492.03
Yr 2 Average monthly cash profit£559.49
+£56.17
Yr 2 Avg annual % of current portfolio cost15.7%
Total Dividends£1,025.03
0
Total Profit from sales£7,249.94
492.03
Average monthly cash profit£438.26
+£21.17
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost12.3%

I've already mentioned the sale of PAF:Pan African Resources and the plan to purchase OPTI:Optibiotix with a fill or kill order. Well as usual that order failed. I decided to be canny - I was in no hurry to buy, and if the share price goes up I'll just look for another share. I set a limit order at 70p when the purchase price was 72p. The share price dropped but not enough to fill the order. Normally I panic at this point and cancel the limit order, just buying at the market price the next day. This time I toughed it out, and much to my joy I was rewarded the next day with a purchase at 69.8p. Bargain! The share price promptly dropped even further.

I looked again at what's about to come along for this company, and I can't believe the price keeps falling. The regularity of the sells suggests that the institutional investors that supported Optibiotix since start-up are continuing to off-load their shares in order to fund other start-ups. While this continues, the share price will keep within this 60p-80p band.

I decided to get some more. I sold my ISA holding of TRX:Tissue Regenix as I still have a load in my pension and they were making £71.32 (12.3%) profit. As part of my new de-risking policy I sold just under half of my holding in TLOU:Tlou Energy for a £328.55 (63%) profit leaving me with 10,000 shares. This liberated £1,479.30 to buy another 2,139 shares in OPTI:Optibiotix at 68.6p. It means my ISA now contains 8,608 shares costing a weighted average of 78.69p which is a significant improvement given my biggest purchase was at 90p. The price hasn't dropped further, with the offer price 69p but the bid price is 67p so I'm losing £1,060 on my ISA and £371.25 in my SIPP, but amazingly making £1.79 profit in my share account!

OPTI:Optibiotix now constitutes 18.1% of my portfolio, so I had better be right about its prospects. I think I am. With Skinbiotix about to list in its own right, a new cholesterol product about to launch, the Go Figure range about to launch in 200 stores of what's rumoured to be Boots, partnership deals with six multi-nationals one of which has been recently confirmed is Tata Chemicals, and a great heap of patents and IP in the micro-biome sphere that's taking off as a major step forward in human health. Oh yes - and a natural sweetener that acts as fibre in the body that's due to launch later this year. I can't look at all that and not be very, very excited. This news item alone shows what's on the horizon: New research presented at Probiota 2017 demonstrates cholesterol-reducing microbiome modulation

Back to the stats. Potential profits only dropped by the amount of profit I made on the sales, so the other £600 was deepening losses. Mainly KIBO:Kibo Mining and OPTI:Optibiotix, but with lots and lots of little losses all adding up. The average monthly profit gets a great boost of £21.17 which is good over an 18 month period.

Not at all good to see the red line go up but the green line go down - and it was all going so well! Hopefully just a blip that's about to be reversed.

The SIPP looks like this after week 65



Weekly Change
Portfolio cost£16,525.19
+£527.66
Portfolio sell value (bid price - commission)£19,243.46(+16.4%)563.01
Potential profits£3,493.13
-£374.17
Yr 2 Dividends£0
+£0
Yr 2 Profit from sales£575.85
502.95
Yr 2 Average monthly cash profit£109.24
+£98.58
Yr 2 Avg annual % of current portfolio cost7.9%
Total Dividends£413.19
+£0
Total Profit from sales£2,925.71
502.95
Average monthly cash profit£217.80
+£30.65
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost15.8%

I did some more de-risking, and sold BMN:Bushveld Minerals for a £502.95 (65.5%) profit. I think they could do really well, but having seen so many penny mining shares tank after being in profit, I decided the risk was too great and there was somewhere much less risky I wanted to increase my holding.

The potential profits decreased less than the profit I made because JLP:Jubilee Platinum climbed 5%. That could be a lot more if they announce maiden platinum production next week! The sell value of the portfolio got a bit hammered though, with small losses in most of the shares. Average monthly profits went up a nice £30.65 keeping performance way above my 10% target.

I used the £1,274.62 liberated by the sale of BMN:Bushveld Minerals to buy another 2,676 shares of IQE:IQE at 47.1849. This was fractionally below the 47.3099p I paid last week and takes my weighted average in the SIPP to 47.25p. Unfortunately they have slipped a little lower to 46.5p bid price so I'm losing £77, but the ISA shares are making potential profit of £1,077 so I'm still a thousand quid up. IQE:IQE now comprises 7.7% of my portfolio and I'd like to get it up to 10%, as like OPTI:Optibiotix it has multiple potential revenue streams and many multi-national partners in an area that's about to go ballistic. This presentation from a year ago really tells the story: PI World IQE Presentation


Oh no! The red line is trying to catch up to the green - shoo!

The trading account looks like this after week 31



Weekly Change
Portfolio cost£986.03
+£0
Cash£75.59
+£0
Portfolio sell value (bid price - commission)£815.36(-17.3%)-£52.04
Potential profits£0
+£0
Dividends£0
0
Profit from sales£61.57
+£0
Average monthly cash profit£8.61
-£0.28
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost10.5%

This account just isn't working out as I had hoped. Both shares dropped in value and my projected income stands at a spectacular £8.61 a month. That won't even pay the window cleaner!


Last week I moaned that the graph was dull. This isn't dull, but I'd actually prefer dull.

A week to forget in terms of share performance, but a week of great satisfaction to make nearly £1,000 profit and increase the holding in my most favourite shares. If OPTI:Optibiotix could have the jolly good manners to announce something spectacular next week, then that would be very much appreciated.

Tuesday, 21 February 2017

Stopped out of Pan African Resources

After re-reading The Naked Trader I decided to set up some stop losses. I'd used them before to save profits, but got stopped out of some shares I really didn't want to sell, so I gave up using them.

However, I've seen some substantial profits get eaten away over the last twelve months, with hundreds of pounds being wiped off the likes of ARL:Atlantis Resources, KIBO:Kibo Mining, RED:RedT Energy and TLOU:Tlou Energy. Rather than using it as a stop loss, I could have used it as a profit protector and either moved on to another share with my money or re-invested at a lower price. With the shares listed above, it would have been a much lower price.

I'd put a stop loss on PAF:Pan African Resources and it triggered today. A worrying and sad RNS yesterday reported a fatal accident during a shaft refurbishment, and this took the price down past my stop limit. The price did climb back a bit higher just afterwards, but it was too late.

I have mixed feelings about the sale. On one hand this is a great and undervalued company, and with the purchase price now higher than my selling price there's no guarantee I can get back in. On the other hand I made a £92 (9.1%) profit from the sale and with the £52.25 dividend finished with a 14% profit which is over my 10% target. It also liberates £1,151.63 in my ISA.

I've decided not to hold on for a drop in the Pan African share price, as things may be a bit rocky for them as a result of the accident, and the next dividend payment isn't until the end of the year, but I will keep them on my radar.

I've set up a fill or kill order for tomorrow morning on OPTI:Optibiotix, as the price has dropped yet again and is too attractive to resist. The offer price is 72p so I've set my price at 71p in the hope of it starting the day a bit lower. If it doesn't fill successfully then I'll get something else. If I'm right and there's a big seller still offloading shares, then I hope there's a good chance there are enough floating around for this price to be accepted.

Meanwhile today has been rubbish. After clawing back another £200 of my overall paper deficit yesterday, I've lost that and another £200 today to go £715 in the red. This wasn't helped by banking £92 profits either. Nearly everything lost money today, so I'm hoping for a better day tomorrow, and hopefully some more lovely Optibiotix shares.

Friday, 17 February 2017

Week 80 Review and Devastating Revelation

This week started really well and then plummeted spectacularly over the last two days. The combined portfolios were in profit Monday, loss Tuesday, profit Wednesday, small loss on Thursday and bigger loss Friday. In the end we are up by just £37.94 on last week, taking the paper deficit to £516.06. The combined portfolio cost sneaked past £59K last week, which should have garnered a "Woohoo!". I did change policy to only do a "Woohoo!" if the value went up another £1K but it's been so yo-yo I don't think I can keep up, so back to doing it on cost.

I've been re-reading The Naked Trader by Robbie Burns. It was such a valuable book when I first read it, and it's even more valuable the second time through, as I'm no longer phased by everything being new and can focus on learning. I decided to check out the website and there were loads of invitations to contact Robbie about his seminars and books. In a moment of enthusiasm I decided to send him an email and thank him for the help the book had been, both when starting out and again now. I decided to send him a link to this blog, as it was kind of inspired by his book.

He very generously replied to my email - but devastation - after the platitudes he went straight for the jugular, commenting that he thinks I'm more of a gambler than an investor due to the high risk nature of my portfolio. I was gob-smacked - nay shell-shocked. My beautiful portfolio that I love so much - how could he say that?

Then the devastating realisation hit me - he's absolutely right. I mean, I've just this week sold two FTSE250 companies to buy two AIM companies, one of which has never made a profit. Looking down my portfolio it's high risk company after high risk company. Oh cripes!

I've been pondering how this came about - and I think it's the excitement of the stories. I look at all my junior shares and they are intrepid explorers of new technology, or producing gold, platinum, and other shiny things.

It's a tricky one though, as I think my attitude has been soured towards the safer blue-chips by the devastation of Brexit. I've been holding some solid FTSE companies for over a year and how are they doing? BDEV:Barratt Developments down 25%, TW.:Taylor Wimpey down 14%, LOOK:Lookers down 30%, MSHL:Marshalls down 20%, VEC:Vectura down 15%. It's not a shining example of successful investment. However, had I bought these same shares on the post-Brexit dip, or topped these up, then maybe my attitude would be very different.

Anyway, the upshot is my risk profile is off the scale and I need to reign it in, so I need to start identifying some safer shares and gradually move out of the smaller AIM companies once the profits are good and get more of the profile into something defensive. A valuable, if rather humbling correspondence!

Back to this week's performance, and I'm overjoyed to say there were no double digit losers - huzzah!

TLOU:Tlou Energy had a second week's double digit climb, going up 14% and making £520 potential profit. This is where I'm really going to struggle putting all the things I just wrote into practice. In theory I should take the 50% profit on this share and put it into something safer - but I just can't - it's such an exciting project - dammit!! I guess I could compromise - keep some shares just so I can watch what happens, but bank my original investment and use it for something sensible - hmm - interesting notion!

Share of the Week was SLP:Sylvania Platinum which climbed 29% and is making potential profit of £274. How glad am I that I sold the holding from my trading account for £65 profit when 2 weeks later it would have made £250 - grr!!

Here's the share and ISA portfolios



Weekly Change
Portfolio cost£42,118.09
+£0
Portfolio sell value (bid price - commission)£38,439.37(-8.7%)+£185.47
Potential profits£2,646.27
+£323.96
Yr 2 Dividends£357.10
+£69.75
Yr 2 Profit from sales£2,917.65
+£0
Yr 2 Average monthly cash profit£503.32
-£7.45
Yr 2 Avg annual % of current portfolio cost14.3%
Total Dividends£1,025.03
+£69.75
Total Profit from sales£6,757.91
+£0
Average monthly cash profit£417.09
-£1.45
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost11.9%

Not too bad, with the value up £185 and paper profits up £323. The £69.75 dividend was from GVC:GVC Holdings and is hopefully the first of many. There - that's one good FTSE250 company in my portfolio! Average monthly performance stayed pretty flat thanks to the dividend.

It's looking promising - slowly but surely closing the gap.

The SIPP looks like this after week 64



Weekly Change
Portfolio cost£15,997.53
+£77.62
Portfolio sell value (bid price - commission)£19,278.81(+20.5%)-£147.37
Potential profits£3,867.30
+£108.82
Yr 2 Dividends£0
+£0
Yr 2 Profit from sales£72.90
+£72.90
Yr 2 Average monthly cash profit£10.66
+£10.66
Yr 2 Avg annual % of current portfolio cost0.1%
Total Dividends£413.19
+£0
Total Profit from sales£2,422.76
+£72.90
Average monthly cash profit£187.15
+£2.05
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost14.0%

A small rise in cost thanks to the sale of JLG:John Laing Group and ALM:Allied Minds and re-investment in OPTI:Optibiotix and IQE:IQE. Although potential profits are up, the portfolio is down thanks to deepening losses in OPTI:Optibiotix, TRX:Tissue Regenix and ARL:Atlantis Resources. The first sales of year 2 means we have some stats, but they're not very impressive! Average monthly profits overall sneak up a little.


That's not too dramatic a fall - I can live with that gap.

The trading portfolio looks like this after week 30



Weekly Change
Portfolio cost£986.03
+£0
Cash£75.59
+£0
Portfolio sell value (bid price - commission)£867.40(-12%)+£0
Potential profits£0
+£0
Dividends£0
0
Profit from sales£61.57
+£0
Average monthly cash profit£8.89
-£0.31
(Sold stocks profit + Dividends - Fees / Months)
Avg annual % of current portfolio cost10.8%

Absolutely no change in either share. Dull, dull, dull, dull, dull.


Dull.

That's it for week 80. Next week may see JLP:Jubilee Platinum announce production of platinum for the first time. A momentous day that I've been awaiting for so long. Not sure if any other news is expected, but we shall see...